Morning-after pill headed OTC?   SCOTT JAGOW: The morning after
pill still isn't available over the counter, but yesterday the
FDA said it might allow over-the-counter sales of Plan B, as the
pill is called. Ashley Milne-Tyte looks at what this could do
for the company that makes it.  ASHLEY MILNE-TYTE: Plan B is
already available via prescription. It brings in about $20
million a year for drug maker Barr Pharmaceuticals. With three
million unplanned pregnancies a year there are plenty of
potential buyers should the drug become more widely available.
Bridget Bailing is with The Tan Sheet, which covers the world of
non-prescription drugs:  BRIDGET BAILING: "I think it remains to
be seen how much of a marketing effort they put behind it
because as of right now the company hasn't done a whole lot to
promote the drug, and everything you've heard about it has been
in the news."  Morningstar analyst Brian Laegeler says over the
counter sales of Plan B could more than double its revenue. But
that won't do much to f